Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TriSalus Life Sciences (TLSI) Assets Average (2022 - 2026)

TriSalus Life Sciences has reported Assets Average over the past 5 years, most recently at $53.2 million for Q1 2026.

  • For Q1 2026, Assets Average rose 102.13% year-over-year to $53.2 million; the TTM value through Mar 2026 reached $53.2 million, up 102.13%, while the annual FY2025 figure was $29.7 million, 22.1% up from the prior year.
  • Assets Average for Q1 2026 was $53.2 million at TriSalus Life Sciences, up from $35.9 million in the prior quarter.
  • Over five years, Assets Average peaked at $250.9 million in Q3 2022 and troughed at $16.4 million in Q2 2023.
  • A 5-year average of $74.7 million and a median of $30.0 million in 2024 define the central range for Assets Average.
  • Biggest five-year swings in Assets Average: crashed 93.46% in 2023 and later surged 102.13% in 2026.
  • Year by year, Assets Average stood at $136.7 million in 2022, then crashed by 78.72% to $29.1 million in 2023, then dropped by 11.53% to $25.7 million in 2024, then soared by 39.55% to $35.9 million in 2025, then surged by 48.08% to $53.2 million in 2026.
  • Business Quant data shows Assets Average for TLSI at $53.2 million in Q1 2026, $35.9 million in Q4 2025, and $38.9 million in Q3 2025.